Translation of drug effects from experimental models of neuropathic pain and analgesia to humans

Drug Discovery Today

Volumn 17, Issue 15-16, 2012, Pages 837-849

  Taneja, Amit ^a   Di Iorio, Vincenzo Luca ^a   Danhof, Meindert ^a   Della Pasqua, Oscar ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BACLOFEN; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; DICLOFENAC; DULOXETINE; FORMALDEHYDE; GABAPENTIN; KETAMINE; KETOROLAC; LAMOTRIGINE; LIDOCAINE; NAPROXEN; OMEGA CONOTOXIN MVIIA; OPIATE; PLACEBO; PREGABALIN; ROFECOXIB; VENLAFAXINE;

ALLODYNIA; ANALGESIA; DATA ANALYSIS; DRUG DEVELOPMENT; DRUG EFFECT; DRUG MEGADOSE; DRUG SCREENING; HUMAN; HYPERALGESIA; INFLAMMATORY PAIN; LOW DRUG DOSE; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PREDICTIVE VALUE; REVIEW; SCIATIC NERVE INJURY;

ANALGESIA; ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, BIOLOGICAL; NEURALGIA;

EID: 84864609840     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.02.010     Document Type: Review

References (82)

1. R.D. Treede Neuropathic pain: redefinition and a grading system for clinical and research purposes Neurology 70 2008 1630 1635
2. M.F. Jarvis, and J.M. Boyce-Rustay Neuropathic pain: models and mechanisms Curr. Pharm. Des. 15 2009 1711 1716
3. B. Nicholson Differential diagnosis: nociceptive and neuropathic pain Am. J. Manag. Care. 12 Suppl. 9 2006 256 262
4. I. Gilron, and T.J. Coderre Emerging dr (Pubitemid 46490733)
5. F.A. White Chemokine signaling and the management of neuropathic pain Mol. Interv. 9 2009 188 195
6. T.S. Jensen, and N.B. Finnerup Neuropathic pain treatment: a further step forward Lancet 374 2009 1218 1219
7. J. Serra Microneurography: an opportunity for translational drug development in neuropathic pain Neurosci. Lett. 470 2010 155 157
8. S.H. Horowitz The diagnostic workup of patients with neuropathic pain Med. Clin. North Am. 91 2007 21 30 (Pubitemid 44880051)
9. International Association for the Study of Pain Neurogenic pain: diagnosis and treatment Pain Clin. Updates III 2 1994 1 8
10. G. Cruccu EFNS guidelines on neuropathic pain assessment: revised 2009 Eur. J. Neurol. 17 2010 1010 1018
11. M. Backonja, and C.J. Woolf Future directions in neuropathic pain therapy: closing the translational loop Oncologist 15 Suppl. 2 2010 24 29
12. B.A. Chizh Predicting therapeutic efficacy - experimental pain in human subjects Brain Res. Rev. 60 2009 243 254
13. D.R. Huntjens Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors Eur. J. Pain 13 2009 448 457
14. D.R. Huntjens Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors Rheumatology (Oxf.) 44 2005 846 859 (Pubitemid 41511177)
15. H. Ueda Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms Pharmacol. Ther. 109 2006 57 77 (Pubitemid 41740815)
16. Y. Jeong, and J.E. Holden Commonly used preclinical models of pain West. J. Nurs. Res. 30 2008 350 364
17. D. Le Bars Animal models of nociception Pharmacol. Rev. 53 2001 597 652 (Pubitemid 33136239)
18. J. Scholz, and C.J. Woolf Can we conquer pain? Nat. Neurosci. 5 2002 1062 1067 (Pubitemid 35247200)
19. G. Cruccu, and A. Truini Neuropathic pain and its assessment Surg. Oncol. 19 2010 149 154
20. D.J. Hewitt Challenges in analgesic drug development Clin. Pharmacol. Ther. 86 2009 447 450
21. M. Zimmermann Pathobiology of neuropathic pain Eur. J. Pharmacol. 429 2001 23 37 (Pubitemid 33043979)
22. G. Blackburn-Munro Pain-like behaviours in animals - how human are they? Trends Pharmacol. Sci. 25 2004 299 305 (Pubitemid 38692421)
23. K. Walker Animal models for pain research Mol. Med. Today 5 1999 319 321 (Pubitemid 29302680)
24. P. Hansson Difficulties in stratifying neuropathic pain by mechanisms Eur. J. Pain 7 2003 353 357 (Pubitemid 36858234)
25. T. Klein Human surrogate models of neuropathic pain Pain 115 2005 227 233 (Pubitemid 40725278)
26. K.A. Herr Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults Clin. J. Pain 20 2004 207 219 (Pubitemid 38802807)
27. R.H. Dworkin Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations Arch. Neurol. 60 2003 1524 1534 (Pubitemid 37443116)
28. K. Meyer-Rosberg Peripheral neuropathic pain - a multidimensional burden for patients Eur. J. Pain 5 2001 379 389 (Pubitemid 34072465)
29. M.J. Millan Descending control of pain Prog. Neurobiol. 66 2002 355 474 (Pubitemid 34606906)
30. T.L. Yaksh Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models Trends Pharmacol. Sci. 20 1999 329 337 (Pubitemid 29366811)
31. A.S. Rice Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards Pain 139 2008 243 247
32. T. Dowdall Comparison of five different rat models of peripheral nerve injury Pharmacol. Biochem. Behav. 80 2005 93 108 (Pubitemid 40126207)
33. J.S. Mogil Animal models of pain: progress and challenges Nat. Rev. Neurosci. 10 2009 283 294
34. R. Hill NK1 (substance P) receptor antagonists - why are they not analgesic in humans? Trends Pharmacol. Sci. 21 2000 244 246 (Pubitemid 30445249)
35. B.A. Chizh Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers Br. J. Anaesth. 98 2007 246 254 (Pubitemid 47072006)
36. I. Kissin The development of new analgesics over the past 50 years: a lack of real breakthrough drugs Anesth. Analg. 110 2010 780 789
37. A. Markou Removing obstacles in neuroscience drug discovery: the future path for animal models Neuropsychopharmacology 34 2009 74 89
38. S. Datta Behavioral and anatomical characterization of the bilateral sciatic nerve chronic constriction (bCCI) injury: correlation of anatomic changes and responses to cold stimuli Mol. Pain 6 2010 7
39. G.T. Whiteside Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans Neuropharmacology 54 2008 767 775
40. J. Gabrielsson Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations Drug Discov. Today 14 2009 358 372
41. G.T. Whiteside, and J.D. Kennedy Consideration of Pharmacokinetic Pharmacodynamic Relationships in the Discovery of New Pain Drugs 2010
42. H. Beier Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antinociceptive response in the presence of competitive antagonism: the interaction between tramadol and its active metabolite on micro-opioid agonism and monoamine reuptake inhibition, in the rat Pharm. Res. 25 2008 1789 1797
43. Y. Matsumura, and H.N. Ananthaswamy Toxic effects of ultraviolet radiation on the skin Toxicol. Appl. Pharmacol. 195 2004 298 308 (Pubitemid 38338650)
44. T. Bishop Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat Pain 131 2007 70 82 (Pubitemid 47193210)
45. F. Cervero, and J.M. Laird Mechanisms of touch-evoked pain (allodynia): a new model Pain 68 1996 13 23 (Pubitemid 126407751)
46. A. Tjolsen The formalin test: an evaluation of the method Pain 51 1992 5 17
47. I. Decosterd, and C.J. Woolf Spared nerve injury: an animal model of persistent peripheral neuropathic pain Pain 87 2000 149 158 (Pubitemid 30621447)
48. W.J. Martin Animal models of neuropathic pain Methods Mol. Med. 84 2003 233 242
49. K.C. Vissers Pharmacological correlation between the formalin test and the neuropathic pain behavior in different species with chronic constriction injury Pharmacol. Biochem. Behav. 84 2006 479 486 (Pubitemid 44292247)
50. C.O. Asante Formalin-induced behavioural hypersensitivity and neuronal hyperexcitability are mediated by rapid protein synthesis at the spinal level Mol. Pain 5 2009 27
51. P.D. Wall Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa Pain 7 1979 103 111
52. G.J. Bennett, and Y.K. Xie A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
53. Z. Seltzer A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218 (Pubitemid 20385185)
54. S.H. Kim, and J.M. Chung An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 50 1992 355 363
55. B.H. Lee An animal model of neuropathic pain employing injury to the sciatic nerve branches NeuroReport 11 2000 657 661 (Pubitemid 30173900)
56. M. Danhof Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research Trends Pharmacol. Sci. 29 2008 186 191
57. G. Bender Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design Pharm. Res. 26 2009 2259 2269
58. G. Bender Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain J. Pharmacol. Exp. Ther. 334 2010 599 608
59. N. Kumar Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate J. Neurochem. 113 2010 552 561
60. A.C. Hooker An evaluation of population D-optimal designs via pharmacokinetic simulations Ann. Biomed. Eng. 31 2003 98 111
61. T.M. Post Disease system analysis: basic disease progression models in degenerative disease Pharm. Res. 22 2005 1038 1049 (Pubitemid 41127061)
62. B. Meibohm, and H. Derendorf Basic concepts of pharmacokinetic/ pharmacodynamic (PK/PD) modelling Int. J. Clin. Pharmacol. Ther. 35 1997 401 413 (Pubitemid 27462583)
63. H. Derendorf, and B. Meibohm Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives Pharm. Res. 16 1999 176 185 (Pubitemid 29135119)
64. D.R. Stanski Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man Anesthesiology 51 1979 235 241 (Pubitemid 9256793)
65. K.P. Zuideveld A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 2001 R2059 R2071
66. W.J. Jusko, and H.C. Ko Physiologic indirect response models characterize diverse types of pharmacodynamic effects Clin. Pharmacol. Ther. 56 1994 406 419 (Pubitemid 24339087)
67. N.L. Dayneka Comparison of four basic models of indirect pharmacodynamic responses J. Pharmacokinet. Biopharm. 21 1993 457 478 (Pubitemid 24025269)
68. A. Sharma, and W.J. Jusko Characterization of four basic models of indirect pharmacodynamic responses J. Pharmacokinet. Biopharm. 24 1996 611 635 (Pubitemid 27406370)
69. Y.N. Sun, and W.J. Jusko Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics J. Pharm. Sci. 87 1998 732 737 (Pubitemid 28268573)
70. D.A. Seminowicz MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain Neuroimage 47 2009 1007 1014
71. L. Jasmin The cold plate as a test of nociceptive behaviors: description and application to the study of chronic neuropathic and inflammatory pain models Pain 75 1998 367 382 (Pubitemid 28160148)
72. E.I. Ette Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies Pharm. Res. 12 1995 729 737
73. M.P. Schaddelee Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5′deoxy-N6-cylopentyladenosine in the mononeuropathic rat Eur. J. Pharmacol. 504 2004 7 15 (Pubitemid 39410717)
74. O.E. Della Pasqua Phamacokinetic-pharmacodynamic modelling of behavioural responses Neurosci. Biobehav. Rev. 23 1998 229 236
75. M. Sigtermans S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers Anesthesiology 111 2009 892 903
76. L. Garcia-Larrea, and M. Magnin Pathophysiology of neuropathic pain: review of experimental models and proposed mechanisms Presse Med. 37 Pt 2 2008 315 340
77. M. Vera-Llonch Treatment of peripheral neuropathic pain: a simulation model Eur. J. Pain 10 2006 279 285 (Pubitemid 43255215)
78. J.E. Frampton, and L.J. Scott Pregabalin: in the treatment of painful diabetic peripheral neuropathy Drugs 64 2004 2813 2820 discussion 2821 (Pubitemid 40007486)
79. D.E. Moulin Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society Pain Res. Manag. 12 2007 13 21 (Pubitemid 46744774)
80. F.P.J. Ezzet Linear, generalised linear, and nonlinear mixed effect models W.P. EtteEI, Pharmacometrics, The Science of Quantitative Pharmacology Vol. 1 2007 John Wiley & Sons 103 135
81. Uchizono J.L.J. Empirical pharmacokinetic/pharmacodynamic models W.P. EtteEI, Pharmacometrics: The science of Quantitative Pharmacology Vol. 1 2007 John Wiley & Sons 529 545
82. D.D. Wang, and S. Zhang Standardized visual predictive check versus visual predictive check for model evaluation J. Clin. Pharmacol. 52 2011 39 54